Should Immunosuppressive Therapy Be Modified During a Pandemic?

Update Item Information
Title Should Immunosuppressive Therapy Be Modified During a Pandemic?
Creator Marc A. Bouffard; Michael Levy; Andrew G. Lee; Gregory P. Van Stavern
Affiliation Department of Neurology (MB), Beth Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Department of Neurology (ML), Mass General and Harvard Medical School, Boston, Massachusetts; Ophthalmology (AL), Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas; and Ophthalmology and Visual Sciences (GVS), St. Louis School of Medicine, Washington University, St. Louis, Missouri
Subject COVID-19; Comorbidity; Eye Diseases; Global Health; Immunosuppression Therapy; Immunosuppressive Agents; Pandemics
OCR Text Show
Date 2021-06
Language eng
Format application/pdf
Type Text
Publication Type Journal Article
Source Journal of Neuro-Ophthalmology, June 2021, Volume 41, Issue 2
Collection Neuro-Ophthalmology Virtual Education Library: Journal of Neuro-Ophthalmology Archives: https://novel.utah.edu/jno/
Publisher Lippincott, Williams & Wilkins
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management © North American Neuro-Ophthalmology Society
ARK ark:/87278/s6569b26
Setname ehsl_novel_jno
ID 1996640
Reference URL https://collections.lib.utah.edu/ark:/87278/s6569b26
Back to Search Results